RC
AGL icon

Renaissance Capital’s Agilon Health AGL Stock Holding History

Renaissance Capital’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,645
Closed -$1.17M – 42
2024
Q1 		$1.17M Buy
7,645
+222
+3% +$36.9K 0.61% 39
2023
Q4 		$2.33M Buy
7,423
+1,548
+26% +$560K 1.14% 30
2023
Q3 		$2.61M Buy
5,875
+1,523
+35% +$688K 1.39% 16
2023
Q2 		$1.89M Buy
4,352
+1,835
+73% +$1.03M 1.07% 24
2023
Q1 		$1.49M Sell
2,517
-266
-10% -$149K 1.11% 25
2022
Q4 		$1.12M Sell
2,783
-93
-3% -$43.6K 0.88% 31
2022
Q3 		$1.68M Sell
2,876
-505
-15% -$302K 1.08% 23
2022
Q2 		$1.84M Buy
3,381
+1,286
+61% +$650K 0.98% 31
2022
Q1 		$1.33M Sell
2,095
-627
-23% -$323K 0.56% 42
2021
Q4 		$1.84M Buy
2,722
+1,417
+109% +$862K 0.47% 49
2021
Q3 		$855K Sell
1,305
-919
-41% -$785K 0.17% 78
2021
Q2 		$2.26M Buy
+2,224
New +$1.95M 0.36% 49

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Capital's AGL Position: Q2 2024 in Review

Renaissance Capital sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 7,645 shares — an estimated $1.17M sold.

Renaissance Capital first reported a position in AGL in Q2 2021 and held it in 12 quarters. The position peaked at $2.61M in Q3 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • Renaissance Capital reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • Renaissance Capital sold 7,645 Agilon Health shares in Q2 2024, an estimated $1.17M.
  • Renaissance Capital first reported a position in Agilon Health in Q2 2021 and held it in 12 quarters.
  • Renaissance Capital's Agilon Health position peaked at $2.61M in Q3 2023.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Renaissance Capital's 13F filing for Q2 2024, filed 11 Jul 2024.